Raphael E Pollock Selected Research

Sarcoma (Soft Tissue Sarcoma)

2/2022	Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers.
1/2022	Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.
6/2020	Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival.
1/2020	Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
1/2020	Extracellular vesicle cross-talk in the liposarcoma microenvironment.
5/2019	Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.
11/2018	Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
8/2017	Autophagy as a potential target for sarcoma treatment.
9/2016	Patterns of major wound complications following multidisciplinary therapy for lower extremity soft tissue sarcoma.
4/2016	NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphael E Pollock Research Topics

Disease

75	Neoplasms (Cancer) 10/2022 - 04/2002
60	Sarcoma (Soft Tissue Sarcoma) 02/2022 - 04/2002
18	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2002
14	Liposarcoma 01/2022 - 04/2012
9	Aggressive Fibromatosis (Desmoid) 01/2020 - 05/2007
9	Neurofibrosarcoma (MPNST) 01/2018 - 05/2009
9	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2014 - 12/2003
8	Leiomyosarcoma 05/2016 - 11/2005
7	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2002
3	Margins of Excision 06/2020 - 05/2003
3	Ewing Sarcoma (Sarcoma, Ewing) 10/2018 - 08/2006
3	Wounds and Injuries (Trauma) 09/2016 - 09/2006
3	Genomic Instability 03/2016 - 01/2011
3	Synovial Sarcoma (Synovioma) 11/2007 - 02/2005
2	Carcinogenesis 01/2020 - 03/2015
2	Neurofibroma 01/2018 - 06/2009
2	Carcinoma (Carcinomatosis) 11/2015 - 11/2005
2	Hemangiosarcoma (Angiosarcoma) 04/2013 - 12/2005
2	Myxoid Liposarcoma 12/2012 - 03/2008
2	Lymphatic Metastasis 04/2009 - 04/2008
2	Fibrosarcoma 09/2008 - 05/2008
2	Disease Progression 01/2007 - 08/2003
2	Fibrosis (Cirrhosis) 07/2002 - 05/2002
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Colonic Neoplasms (Colon Cancer) 05/2019
1	Cachexia 12/2018
1	Lewis Lung Carcinoma 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	Warts (Wart) 10/2018
1	Desmoplastic Small Round Cell Tumor 10/2018
1	Neurilemmoma (Schwannoma) 01/2018
1	Neurofibromatoses (Neurofibromatosis) 01/2018
1	Thrombosis (Thrombus) 08/2017
1	Venous Thromboembolism 08/2017
1	Heart Arrest (Cardiac Arrest) 08/2017

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2005
9	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2011
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2002
9	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 12/2003
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2013 - 04/2002
6	CateninsIBA 01/2020 - 04/2012
5	ParaffinIBA 07/2013 - 01/2005
4	Phosphotransferases (Kinase)IBA 01/2022 - 04/2002
4	Messenger RNA (mRNA)IBA 01/2019 - 11/2006
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2005
4	SurvivinIBA 01/2018 - 12/2011
4	Biological ProductsIBA 01/2018 - 08/2006
3	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2010
3	MicroRNAs (MicroRNA)IBA 12/2018 - 04/2012
3	Pharmaceutical PreparationsIBA 07/2014 - 03/2008
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2008 - 04/2002
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2022 - 02/2005
2	SAR405838IBA 01/2022 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 08/2012
2	Histone Deacetylase InhibitorsIBA 01/2016 - 05/2009
2	Enhancer of Zeste Homolog 2 ProteinIBA 03/2015 - 01/2014
2	3' Untranslated Regions (3' UTR)IBA 03/2015 - 02/2014
2	Tyrosine Kinase InhibitorsIBA 08/2014 - 09/2008
2	Histones (Histone)IBA 01/2014 - 05/2009
2	Cadherins (E-Cadherin)IBA 10/2013 - 11/2010
2	Formaldehyde (Formol)FDA Link 07/2013 - 12/2007
2	Ifosfamide FDA LinkGeneric 12/2012 - 09/2002
2	Cyclin D1IBA 04/2012 - 05/2009
2	PlasticsIBA 11/2011 - 10/2004
2	Complement System Proteins (Complement)IBA 01/2011 - 02/2007
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2010 - 11/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2008 - 04/2002
2	LigandsIBA 05/2008 - 03/2008
2	Monoclonal AntibodiesIBA 09/2006 - 04/2002
1	berzosertibIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	SynaptophysinIBA 02/2021
1	DesminIBA 02/2021
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Proto-Oncogene Proteins c-mdm2IBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 05/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2019
1	Fluorouracil (Carac)FDA LinkGeneric 05/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Caspase 3 (Caspase-3)IBA 12/2018
1	Toll-Like Receptor 7IBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	Neurofibromin 2 (Merlin)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	CytokinesIBA 01/2017

Therapy/Procedure

44	Therapeutics 01/2022 - 01/2002
23	Radiotherapy 06/2020 - 04/2002
12	Drug Therapy (Chemotherapy) 05/2019 - 04/2002
7	Neoadjuvant Therapy 06/2020 - 09/2002
2	Limb Salvage 06/2020 - 10/2004
2	Adjuvant Chemotherapy 01/2020 - 12/2003
2	Surgical Amputation (Amputations) 08/2017 - 08/2002
2	Laparotomy 04/2006 - 08/2003
1	Palliative Care (Palliative Therapy) 01/2020
1	Cytoreduction Surgical Procedures 10/2018
1	Hyperthermic Intraperitoneal Chemotherapy 10/2018
1	Sternotomy 08/2017
1	Embolectomy 08/2017